NCT02564042 - A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis | Biotech Hunter

Enrollment

227

Participants

Timeline

Start Date

November 23, 2015

Primary Completion Date

October 1, 2016

Study Completion Date

October 5, 2016

Conditions

Psoriasis

Interventions

DRUG

GSK2894512 1% Cream

1.0% (10 mg/g) GSK2894512 will be supplied as white to off-white cream to be applied topically

DRUG

GSK2894512 0.5% Cream

0.5% (5 mg/g) GSK2894512 will be supplied as white to off-white cream to be applied topically

DRUG

Vehicle cream

White to off-white vehicle cream base to be applied topically

Trial Locations (46)

15213

GSK Investigational Site, Pittsburgh

19103

GSK Investigational Site, Philadelphia

27262

GSK Investigational Site, High Point

33142

GSK Investigational Site, Miami

37072

GSK Investigational Site, Goodlettsville

40217

GSK Investigational Site, Louisville

46168

GSK Investigational Site, Plainfield

48059

GSK Investigational Site, Fort Gratiot Township

60612

GSK Investigational Site, Chicago

66215

GSK Investigational Site, Overland Park

77004

GSK Investigational Site, Houston

77598

GSK Investigational Site, Webster

78229

GSK Investigational Site, San Antonio

78705

GSK Investigational Site, Austin

92123

GSK Investigational Site, San Diego

98101

GSK Investigational Site, Seattle

06032

GSK Investigational Site, North Logan

02919

GSK Investigational Site, Johnston

V3R 6A7

GSK Investigational Site, Surrey

L8N 1V6

GSK Investigational Site, Hamilton

L3P1X2

GSK Investigational Site, Markham

P1B 3Z7

GSK Investigational Site, North Bay

L6J 7W5

GSK Investigational Site, Oakville

K2G 6E2

GSK Investigational Site, Ottawa

K9J5K2

GSK Investigational Site, Peterborough

L4B 1A5

GSK Investigational Site, Richmond Hill

N2J 1C4

GSK Investigational Site, Waterloo

N8W 1E6

GSK Investigational Site, Windsor

N8W 5L7

GSK Investigational Site, Windsor

H2K 4L5

GSK Investigational Site, Montreal

G1V4X7

GSK Investigational Site, Québec

813-0044

GSK Investigational Site, Fukuoka

819-0373

GSK Investigational Site, Fukuoka

006-0022

GSK Investigational Site, Hokkaido

066-0021

GSK Investigational Site, Hokkaido

066-0064

GSK Investigational Site, Hokkaido

221-0825

GSK Investigational Site, Kanagawa

861-3101

GSK Investigational Site, Kumamoto

572-0838

GSK Investigational Site, Osaka